PRKCE and Insulin resistance: At the molecular level, DAG has been shown to inhibit the tyrosine kinase activity of the insulin receptor [118] via activation of protein kinase C-ε (PKC-ε) [119] in the liver [60,120], which, at the intracellular level, impairs the downstream signaling cascade of insulin, resulting in insulin resistance [121].